awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q26745422-0B961453-69D1-4A13-ABC2-3E7C28BC6201
Q26745422-0B961453-69D1-4A13-ABC2-3E7C28BC6201
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26745422-0B961453-69D1-4A13-ABC2-3E7C28BC6201
Pemetrexed for advanced stage nonsquamous non-small cell lung cancer: latest evidence about its extended use and outcomes
P2860
Q26745422-0B961453-69D1-4A13-ABC2-3E7C28BC6201
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26745422-0B961453-69D1-4A13-ABC2-3E7C28BC6201
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
461db3c7c5b0fd47bcda21ba5cec01a82fa319ab
P2860
Phase II trial of pemetrexed plus bevacizumab for second-line therapy of patients with advanced non-small-cell lung cancer: NCCTG and SWOG study N0426.